C ompared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

such as the intra-aortic balloon pump. Now some 40 years since its first-in-man description, the situations and strategies in which to utilize its attractive physiological properties are still ...

(European Heart Journal) In heart failure complicated by cardiogenic shock, early intra-aortic balloon pump (IABP) placement did not help clinical outcomes in the small randomized trial Altshock-2.

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

On Sunday April 20, Hamad Medical Corporation (HMC) welcomed US Ambassador to Qatar H E Timmy Davis who visited the Heart ...